Labiana Health S.A. Cash Flow Conversion Efficiency

Latest as of December 2022: 0.604x

Labiana Health S.A. cash flow conversion efficiency. Based on the latest financial reports, Labiana Health S.A. (LAB) has a cash flow conversion efficiency ratio of 0.604x as of December 2022. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (€4.68 Million ≈ $5.47 Million USD) by net assets (€7.74 Million ≈ $9.05 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see LAB stock market capitalisation for the company's overall valuation and market capitalisation.

Cash Flow Conversion Efficiency of Labiana Health S.A. (2021–2025)

Cash flow conversion efficiency of Labiana Health S.A. from 2021 to 2025. This chart illustrates how Labiana Health S.A.'s cash flow conversion efficiency has evolved over time, based on yearly financial data. View LAB stock price for real-time trading data and today's change.

Labiana Health S.A. Cash Flow Conversion Ratio Explained

Labiana Health S.A. cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.

Labiana Health S.A. Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Labiana Health S.A. ranked by their cash flow conversion efficiency. Review LAB cash flow after capex ratio to assess how much free cash flow the company generates relative to operating cash flow.

Company	Cash Flow Conversion Efficiency
Kairous Acquisition Corp Ltd NASDAQ:KACL	-0.008x
Mustek Ltd JSE:MST	-0.048x
Ananda Development Public Company Limited BK:ANAN	0.067x
Green Cross Medical Science Corporation KQ:142280	-0.013x
Mercury Corporation KQ:100590	0.029x
Advani Hotels & Resorts (India) Limited NSE:ADVANIHOTR	0.016x
Senko Co. Ltd KQ:347000	0.022x
Caribou Biosciences Inc NASDAQ:CRBU	-0.232x

Annual Cash Flow Conversion Efficiency for Labiana Health S.A. (2021–2025)

The table below shows the annual cash flow conversion efficiency of Labiana Health S.A. from 2021 to 2025. Also see Labiana Health S.A. assets under control for a full breakdown of the balance sheet.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	€4.76 Million ≈ $5.56 Million	€1.70 Million ≈ $1.99 Million	0.357x	-87.25%
2024-12-31	€2.57 Million ≈ $3.00 Million	€7.19 Million ≈ $8.41 Million	2.801x	+622.10%
2023-12-31	€3.40 Million ≈ $3.98 Million	€-1.83 Million ≈ $-2.13 Million	-0.536x	-188.78%
2022-12-31	€7.74 Million ≈ $9.05 Million	€4.68 Million ≈ $5.47 Million	0.604x	+78.22%
2021-12-31	€11.52 Million ≈ $13.47 Million	€3.91 Million ≈ $4.57 Million	0.339x	--

About Labiana Health S.A.

MC:LAB Spain Drug Manufacturers - Specialty & Generic

Market Cap

$51.61 Million

€44.14 Million EUR

Market Cap Rank

#22093 Global

#163 in Spain

Share Price

€5.20

Change (1 day)

-3.70%

52-Week Range

€4.28 - €7.55

All Time High

€7.55